Hong-bin LV

Prof. Hong-bin LV

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
WHWei He
Wei He
PTPanli Tang
Panli Tang
HLHong-bin LV
Hong-bin LV
Diabetic retinopathy (DR) is a common and severe microvascular complication of diabetes, leading to vision impairment and blindness, particularly in working-age adults. Oxidative stress plays a central role in the pathogenesis of DR, with excessive reactive oxygen species (ROS) damaging retinal tissues, including blood vessels and neurons. This oxidative damage is exacerbated through various metabolic pathways, such as the polyol pathway, protein kinase C(PKC) activation, and advanced glycation end-product(AGE) formation. Additionally, mitochondrial dysfunction, retinal cell apoptosis, inflammation, and lipid peroxidation are key pathological processes associated with oxidative stress in DR. Epigenetic modifications, including DNA methylation and histone alterations, further contribute to gene expression changes induced by oxidative stress. To mitigate oxidative damage, therapeutic strategies targeting ROS production, neutralizing free radicals, and enhancing antioxidant defenses hold promise. Various natural antioxidant compounds, such as polyphenols (e.g., epigallocatechin-3-gallate, quercetin, resveratrol) and carotenoids (e.g., lutein, zeaxanthin), have demonstrated potential in reducing oxidative stress and improving retinal health in DR models. Moreover, activation of the Nrf2 and SIRT1 pathways has emerged as a promising approach to enhance the antioxidant response. Although preclinical studies show promising results, further clinical trials are necessary to validate the efficacy and safety of these therapeutic strategies. In conclusion, a better understanding of the molecular mechanisms underlying oxidative stress in DR and the development of multi-target therapies could provide more effective treatment options for DR patients.

20 March 2019 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
JCJingliang Cheng
Jingliang Cheng
JFJiewen Fu
Jiewen Fu
QZQi Zhou
Qi Zhou
XXXiaohong Xiang
Xiaohong Xiang
CWChunli Wei
Chunli Wei
JFJunjiang Fu
Junjiang Fu

15 December 2023 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
BDBo Deng
Bo Deng
MZMo Zhou
Mo Zhou
XKXiangmei Kong
Xiangmei Kong
LLLinbi Luo
Linbi Luo
HLHong-bin LV
Hong-bin LV
Purpose: The aim of this study was to evaluate the effectiveness and safety of repeated low-level red light (RLRL) therapy in controlling myopia progression in children through a meta-analysis. Methods: We searched several databases including PubMed, Embase, The Cochrane Library, Web of Science, CNKI, WANFANG, CBM, and VIP with languages restricted to both Chinese and English. The search was conducted from the establishment of the databases to March 23, 2023. We collected randomized controlled trials and controlled experiments to evaluate changes in axial length (AL) and spherical equivalent (SE) before and after RLRL intervention. Two researchers performed literature screening and data extraction, and RevMan software (Ver 5.3) and StataMP 17.0 were used for meta-analysis. Results: A total of 141 articles were retrieved, and finally, six randomized controlled trials met the inclusion and exclusion criteria, including 820 eyes (RLRL group: 411 eyes, control group: 409 eyes). The meta-analysis results showed that the RLRL group was significantly better than the control group in controlling AL, and the difference between the two groups was statistically significant (mean difference [MD] = −0.22, 95% confidence interval [CI] [ - 0.28, −0.16]; P < 0.001). The RLRL group was also better than the control group in terms of SE, and the difference between the two groups was statistically significant (MD = 0.46, 95% CI [0.32, 0.6]; P < 0.001). Five studies reported adverse reactions in the RLRL group, and two cases stopped treatment due to the feeling of too bright light, while the others had no significant side effects in the short term. Conclusion: RLRL therapy is a safe and effective method for controlling myopia, which can inhibit the growth of AL and slow down the progression of myopia. However, further research and validation are needed to determine its treatment efficacy and course.

28 September 2022 in Ophthalmic Research
Verified
Journal Article
Open access
PDF file
YTYong Tang
Yong Tang
XGXiaorong Gao
Xiaorong Gao
WWWeijia Wang
Weijia Wang
YDYujiao Dan
Yujiao Dan
LZLinjing Zhou
Linjing Zhou
YHYue He
Yue He
Introduction: Development and validation of a deep learning algorithm to automatically identify and locate epiretinal memberane (ERM) regions in OCT images. Methods: OCT images of 468 eyes were retrospectively collected from a total of 404 ERM patients. One expert manually annotated the ERM regions for all images. A total of 422 images (90%) and the remainig 46 images (10%) were used as the training dataset and validation dataset for deep learning algorithm training and validation, respectively. One senior and one junior clinician read the images. The diagnostic results were compared. Results: The algorithm accurately segmented and located the ERM regions in OCT images. The image-level accuracy was 95.65%, and the ERM region-level accuracy was 90.14%, respectively. In comparison experiments, the accuracies of the junior clinician improved from 85.00% to 61.29% without the assistance of the algorithm to 100.00% and 90.32% with the assistance of the algorithm. The corresponding results of the senior clinician were 96.15%, 95.00% without the assistance of the algorithm, and 96.15%, 97.50% with the assistance of the algorithm. Conclusions: The developed deep learning algorithm can accurately segment ERM regions in OCT images. This deep learning approach may help clinicians in clinical diagnosis with better accuracy and efficiency.

8 July 2024 in Biology Direct
Verified
Journal Article
Open access
PDF file
QZQi Zhou
Qi Zhou
MTMin Tian
Min Tian
YCYang Cao
Yang Cao
MTMin Tang
Min Tang
XXXiaohong Xiang
Xiaohong Xiang
HLHong-bin LV
Hong-bin LV
Objective: Retinal vascular endothelial cell (RVECs) injury is a major cause of morbidity and mortality among the patients with diabetes. RVECs dysfunction is the predominant pathological manifestation of vascular complication in diabetic retinopathy. N6-methyladenosine (m6A) serves as the most prevalent modification in eukaryotic mRNAs. However, the role of m6A RNA modification in RVECs dysfunction is still unclear. Methods: RT-qPCR analysis and western blot were conducted to detect the change of m6A RNA modification in diabetic retinopathy. CCK-8 assay, transwell experiment, wound healing assay, tube formation experiment, m6A-IP-qPCR were performed to determine the role of YTHDC1 in RVECs. Retinal trypsin digestion test and H&E staining were used to evaluate histopathological changes. Results: The levels of m6A RNA methylation were significantly up-regulated in HG-induced RVECs, which were caused by increased expression of YTHDC1. YTHDC1 regulated the viability, proliferation, migration and tube formation ability in vitro. YTHDC1 overexpression impaired RVECs function by repressing CDK6 expression, which was mediated by YTHDC1-dependent mRNA decay. Moreover, it showed sh-YTHDC1 inhibited CDK6 nuclear export. Sh-YTHDC1 promotes the mRNA degradation of CDK6 in the nucleus but does not affect the cytoplasmic CDK6 mRNA. In vivo experiments showed that overexpression of CDK6 reversed the protective effect of sh-YTHDC1 on STZ-induced retinal tissue damage. Conclusion: YTHDC1-mediated m6A methylation regulates diabetes-induced RVECs dysfunction. YTHDC1-CDK6 signaling axis could be therapeutically targeted for treating DR.

26 October 2018 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
JHJunting Huang
Junting Huang
JFJiewen Fu
Jiewen Fu
SFShangyi Fu
Shangyi Fu
LYLisha Yang
Lisha Yang
KNKailai Nie
Kailai Nie
JFJunjiang Fu
Junjiang Fu
Background/Aim: Gyrate atrophy of the choroid and retina (GACR) is an extremely rare autosomal recessive inherited disorder characterised by progressive vision loss. To identify the disease-causing gene in a consanguineous Chinese pedigree with GACR, we aimed to accurately diagnose patients with GACR through a combination of next-generation sequencing (NGS) genetic diagnosis, clinical imaging and amino acid metabolic analysis. Methods: A consanguineous Chinese pedigree with GACR, including two patients, was recruited and a comprehensive ophthalmological evaluation was performed. DNA was extracted from a proband and her family members, and the sample from the proband was analysed using targeted NGS. Variants ‎detected by NGS were confirmed by Sanger sequencing and subjected to segregation analysis. Tandem mass spectrometry (MS/MS) was subsequently performed for metabolic assessment. Results: We identified a ‎novel, deleterious, homologous ornithine aminotransferase ( OAT ) variant, c.G248A: p.S83N, which contributes to ‎the progression of GACR in patients. Our results showed that the p.S83N autosomal recessive ‎variant of OAT is most likely ‎pathogenic, with changes in protein stability drastically decreasing functionality. MS/MS verified that ornithine levels in patients were significantly elevated. Conclusions: Recruitment of a third-degree first cousin consanguineous marriage family with GACR allowed us to identify a novel pathogenic OAT variant in the Chinese population, broadening the mutation spectrum. Our findings reported the diagnostic value of a combination of NGS, retinal imaging and metabolic analysis of consanguineous marriage pedigrees in low-income/middle-income and low-incidence countries, including China, and may help to guide accurate diagnosis and ‎treatment of this disease.